Exercise for Parkinson's Disease
(EXCEL-PD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a home-based exercise program to determine its effectiveness for people with Parkinson's disease. Researchers aim to discover whether combining endurance exercises, such as treadmill running, with resistance training can enhance movement and cognitive skills. Participants will exercise at home with virtual guidance from trainers, while the control group will maintain their usual activities. Individuals with Parkinson's who experience symptoms like tremors or stiffness and do not already exercise frequently might be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to understanding how exercise can benefit those with Parkinson's.
Will I have to stop taking my current medications?
The trial requires that if you are taking Parkinson's disease medications, your doses must be stable for at least 2 months before starting. If you are not on these medications, you should not need them for the next 6 months. Other medications, like certain psychotropic drugs, need to have stable doses for at least 30 days before starting.
What prior data suggests that this exercise program is safe for people with Parkinson's disease?
Research has shown that exercise is generally safe for people with Parkinson's disease. Studies have found that physical activity can improve balance, movement, and flexibility, and it can also benefit non-motor symptoms like mood and sleep. However, the risk of negative effects, such as injuries, remains unclear, and researchers are not completely certain about the level of risk.
One study found that people with mild to moderate Parkinson's disease did not report any major safety concerns when participating in exercise programs. This suggests that exercise might be well-tolerated. Activities like walking on a treadmill, dancing, and tai chi have demonstrated positive effects on the disease's progression without major safety issues.
In summary, while exercise appears helpful and generally safe for people with Parkinson's, the exact risk of negative effects is uncertain. Participants should follow guidance from exercise trainers to minimize any potential risks.12345Why are researchers excited about this trial?
Unlike standard treatments for Parkinson's, which often involve medications like levodopa or dopamine agonists to manage symptoms, this approach focuses on exercise as a therapeutic method. Researchers are excited because the exercise program combines endurance and resistance training, which could offer a natural way to improve motor function and overall health. Conducted at home with virtual supervision, this method provides flexibility and accessibility, potentially enhancing adherence and making it easier for patients to integrate into their daily lives.
What evidence suggests that exercise is effective for Parkinson's disease?
This trial will compare the effects of exercise with a waitlist control group for individuals with Parkinson's disease. Studies have shown that exercise can improve movement and reduce symptoms in people with Parkinson's disease. For example, aerobic and resistance training can enhance mobility and balance. Research also suggests that regular activity can lead to better long-term health for those with Parkinson's. Exercise has even been linked to improvements in mood and thinking skills. Overall, staying active appears to be a powerful way to help manage Parkinson's disease.12467
Who Is on the Research Team?
Nijee Luthra, MD, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for people aged 40-80 with Parkinson's disease who are stable on their PD medications or unlikely to need them in the next 6 months. They should be able to follow exercise instructions without significant cognitive impairment (MoCA score ≥23) and not have severe depression (BDI ≤16). Participants must not have major cardiovascular, metabolic, renal diseases, or other conditions that would make exercising unsafe.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a home-based, trainer-supervised endurance and resistance training program for 26 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants in the waitlist control group are offered the exercise program after the 26-week study period
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
- No Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator